SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-09-005350
Filing Date
2009-04-15
Accepted
2009-04-15 16:00:41
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K c83824e10vk.htm 10-K 501791
2 EXHIBIT 10.4 c83824exv10w4.htm EX-10.4 57113
3 EXHIBIT 10.5 c83824exv10w5.htm EX-10.5 59619
4 EXHIBIT 10.6 c83824exv10w6.htm EX-10.6 63278
5 EXHIBIT 10.7 c83824exv10w7.htm EX-10.7 55681
6 EXHIBIT 23.1 c83824exv23w1.htm EX-23.1 1475
7 EXHIBIT 31.1 c83824exv31w1.htm EX-31.1 9060
8 EXHIBIT 31.2 c83824exv31w2.htm EX-31.2 9078
9 EXHIBIT 32.1 c83824exv32w1.htm EX-32.1 3916
10 EXHIBIT 32.2 c83824exv32w2.htm EX-32.2 3997
  Complete submission text file 0001362310-09-005350.txt   766553
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 09751161
SIC: 2834 Pharmaceutical Preparations